The chance of receiving recommended therapies to reduce the risk of stroke varies 16-fold across England, finds a new report published by the Association of the British Pharmaceutical Industry’s Stroke in Atrial Fibrillation Initiative.
Read More
The UK’s Medicines and Healthcare products Regulatory Agency is considering whether to allow over-the-counter sales of erectile dysfunction drug sildenafil, which was originally on the market under the brand name Viagra.
Read More
Therapy will be available on the NHS as a clinical treatment option for adults with COVID-19
Read MoreThe NHS could have saved millions last year if an ongoing patent case had not restricted the use of generic pregabalin, a new analysis claims.
Read More
The original patent for pregabalin (Lyrica) as a treatment for epilepsy expired in 2014, paving the way for generic formulations, however, the firm had secured a second-use patent for pregabalin as a treatment for pain until July 2017.
Read More
